Moderna

YTD

ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.

CEO

Stéphane Bancel

CEOStéphane Bancel

Employees

5,800

Employees5,800

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2010

Founded2010

Employees

5,800

Employees5,800

MRNA Key Statistics

Market cap

10.90B

Market cap10.90B

Price-Earnings ratio

-3.73

Price-Earnings ratio-3.73

Dividend yield

—

Dividend yield—

Average volume

8.37M

Average volume8.37M

High today

$28.59

High today$28.59

Low today

$26.80

Low today$26.80

Open price

$26.97

Open price$26.97

Volume

9.39M

Volume9.39M

52 Week high

$91.99

52 Week high$91.99

52 Week low

$23.15

52 Week low$23.15

MRNA News

Seeking Alpha 16h

Short bets on S&P 500 Healthcare sector ease in July; Moderna remains most heavily shorted stock

The average short interest in the S&P 500 Health Care Index Sector (NYSEARCA:XLV) dipped slightly in July to 1.95% from 1.96% in June. However, Moderna (NASDAQ:...

Analyst ratings

63%

of 27 ratings

Buy

22.2%

Hold

63%

Sell

14.8%

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.